With more than 80% of trials behind schedule, current trial site recruitment is an uneven practice with reliance on fragmented or "homegrown" data sources that are "snapshots" of past experience.
Identification of potential patient enrollment for a trial protocol often is based on the trial site coordinator's estimates rather than known patient volumes by therapeutic area. As a result, a majority of trials end up in "alert" or "rescue" mode which drives additional R&D spending to recover from delays.
Clinical Investigators helps pharmaceutical and biotechnology companies accelerate trial site recruitment with improved accuracy and quality, which helps avoid rescue mode, lowers overall trial costs and reduces lost revenue due to slower FDA approvals.
Latest News
Health Market Science Launches Clinical Investigators™
Upcoming Events